Bal Pharma dividend 2025

BALPHARMA

88.54

0.70 (0.80%)
Last updated on 18 Aug, 2025 | 15:30 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bal Pharma Dividend Details

Record Date

18-Sep-2025

Ex Date

18-Sep-2025

Dividend Type

Equity Share

Dividend Per Share

12.00

Bal Pharma Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
18-Sep-20250.12Equity Share18-Sep-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
Premier Explosives Ltd.0.2522-May-202523-Sep-202523-Sep-2025
Signet Industries Ltd.0.0530-May-202523-Sep-202523-Sep-2025
SMS Pharmaceuticals Ltd.0.430-May-202522-Sep-202522-Sep-2025
Ruchira Papers Ltd.0.526-May-202522-Sep-202522-Sep-2025
Compucom Software Ltd.0.127-May-202520-Sep-202519-Sep-2025
BCL Industries Ltd.0.2629-May-202519-Sep-202519-Sep-2025
Indo-National Ltd.120-May-202519-Sep-202519-Sep-2025
HLE Glascoat Ltd.0.5519-May-202519-Sep-202519-Sep-2025
Shaily Engineering Plastics Ltd.113-May-202519-Sep-202519-Sep-2025
Goldiam International Ltd.0.526-May-202519-Sep-202519-Sep-2025

Bal Pharma Dividend FAQs

The latest dividend declared by Bal Pharma is of 0.12 per share for the financial year as announced on 18-Sep-2025.

Registered shareholders who own Bal Pharma’s shares on or before the record date of 18-Sep-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Sep-2025.

You can expect to receive Bal Pharma’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Sep-2025. The record date is when Bal Pharma identifies eligible shareholders for the dividend payment.

The annual dividend paid by Bal Pharma varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Bal Pharma's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.